These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7349726)

  • 21. Safety considerations in assessing the role of immunotherapy in allergic disorders.
    Bousquet J; Michel FB
    Drug Saf; 1994 Jan; 10(1):5-17. PubMed ID: 8136087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment by HDM (house dust mite) of respiratory tract allergies to house dust acarians. Apropos of 300 cases].
    Saad H
    Tunis Med; 1986; 64(6-7):603-6. PubMed ID: 3787748
    [No Abstract]   [Full Text] [Related]  

  • 23. [The allergic environment and hyposensitization].
    Terho A; Haahtela T
    Duodecim; 1981; 97(9):596-609. PubMed ID: 7274139
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 25. [How great is the value of oral hyposensitization in skin test assessed allergy in comparison with parenteral treatment?].
    Luger T
    Internist (Berl); 1996 May; 37(5):519-20. PubMed ID: 9011553
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergenic extracts: a review of their safety and efficacy.
    Schaeffer M; Sisk LC
    Ann Allergy; 1984 Jan; 52(1):2-14. PubMed ID: 6364894
    [No Abstract]   [Full Text] [Related]  

  • 27. High adherence to hymenoptera venom subcutaneous immunotherapy over a 5-year follow-up: A real-life experience.
    Bilò MB; Kamberi E; Tontini C; Marinangeli L; Cognigni M; Brianzoni MF; Garritani MS; Antonicelli L
    J Allergy Clin Immunol Pract; 2016; 4(2):327-9.e1. PubMed ID: 26563675
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunochemical effects of injection therapy with allergens by customary and intensive dosage regimens in children.
    May CD; Lyman M; Alberto R; Aduna N
    Pediatrics; 1972 Apr; 49(4):536-46. PubMed ID: 4111132
    [No Abstract]   [Full Text] [Related]  

  • 29. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 30. [Specific hyposensitization].
    Bartsch P
    Rev Med Liege; 1984 May; 39(9):349-53. PubMed ID: 6729306
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunotherapy throughout the decades: from Noon to now.
    Finegold I; Dockhorn RJ; Ein D; Dolen WK; Oppenheimer J; Potter LH
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):328-36; quiz 337, 358. PubMed ID: 21055658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Specific and nonspecific hyposensitization of animals with experimental allergy to the antigen from Dermatophagoides pteronyssinus mites].
    Ivanov LN
    Patol Fiziol Eksp Ter; 1979; (1):44-8. PubMed ID: 424244
    [No Abstract]   [Full Text] [Related]  

  • 33. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergy to Alternaria. I. Clinical aspects.
    Granel C; Tapias G; Valencia M; Randazzo L; Anglada E; Olivé A
    Allergol Immunopathol (Madr); 1993; 21(1):15-9. PubMed ID: 8328352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific hyposensitization of respiratory allergies with a new, tetrahydrofuran-treated semi-depot extract: a two-year study on effects and side effects.
    Rudolph R; Staud RD; Baumgarten C; Kunkel G
    Lung; 1978; 155(4):297-308. PubMed ID: 732351
    [No Abstract]   [Full Text] [Related]  

  • 36. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
    Grevers G
    MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
    [No Abstract]   [Full Text] [Related]  

  • 37. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study.
    Marogna M; Massolo A
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):133-40. PubMed ID: 12793117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].
    Pacor ML; Biasi D
    Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and its persistence, in children and adults.
    Di Rienzo V
    Int J Immunopathol Pharmacol; 2005; 18(4 Suppl):35-7. PubMed ID: 17761106
    [No Abstract]   [Full Text] [Related]  

  • 40. Allergen immunotherapy (desensitisation) for allergic diseases.
    Durham SR
    Clin Med (Lond); 2006; 6(4):348-51. PubMed ID: 16956138
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.